Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled

Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.

We haven't written up this one. CNBC World has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at cnbc.com →

More in Health & Medicine

More from Tuesday 3 November →